This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aop Orphan Pharmaceuticals Ag. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Agnes Kohl - Innovator in Cannabinoid Research
Introduction
Agnes Kohl is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of cannabinoid research, particularly in the context of cancer treatment. Her innovative approach focuses on the use of cannabinoids for the prophylactic treatment of involuntary weight loss in cancer patients.
Latest Patents
Agnes Kohl holds 1 patent for her invention titled "Cannabinoids for prophylactic treatment of involuntary weight loss." This patent outlines a new use for cannabinoids in preventing pre-cachexia or cachexia in patients suffering from cancer. The invention emphasizes administering cannabinoids at low dosages, starting prior to chemotherapy, and maintaining the treatment throughout the chemotherapy duration.
Career Highlights
Throughout her career, Agnes has worked with AOP Orphan Pharmaceuticals AG and AOP Orphan Pharmaceuticals GmbH. These companies are known for their focus on developing treatments for rare diseases, which aligns with her innovative research in cannabinoid applications.
Collaborations
Agnes has collaborated with Ralf Lenhard, contributing to her research and development efforts in the field of cannabinoid therapy.
Conclusion
Agnes Kohl's work in cannabinoid research represents a significant advancement in the treatment of cancer-related weight loss. Her innovative patent and collaborations highlight her commitment to improving patient care through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile